Sensus Healthcare Q1 revenue $10.7M (up 214% YoY); net income $2.3M vs loss of $1.9M

Sensus Healthcare, Inc.

2024-Q1 EPS reported $0.14 revenue$10,663,000

Revenue $10.7M, up 214% from $3.4M; shipped 26 systems vs 10 YoY.
Net income $2.3M ($0.14 diluted EPS) vs net loss $1.9M ($0.12 loss) YoY.
Adjusted EBITDA $3.0M vs negative $2.7M YoY.
Launched 'Fair Deal Agreement' recurring revenue program; cash $14.7M, no debt.
Sold first SRT-100 Vision in Asia (Taiwan) and first veterinary unit outside U.S. (Israel).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Sensus Healthcare, Inc. reported the three months ended March 31, 2024 results: revenue $10.7 million, net income $2.3 million, or $0.14 per diluted share, EPS $0.14 per diluted share.

Period: the three months ended March 31, 2024
Revenue: $10.7 million
Net income: $2.3 million, or $0.14 per diluted share
EPS: $0.14 per diluted share
Result: reported results

Exact text from the filing

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold · Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Sensus Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-041314

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.